GAUDIUMIVFNSEGaudium IVF and Women Health LimitedHighNeutral
Announced Thu, 25 Jun · 21:32 IST

Corrigendum to FY26 results, fixes minor clerical errors in FY25 comparatives

Revenue Growth 20pctPat Growth 25pctResults RestatedResults View source PDF

GAUDIUMIVF · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹108.63
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+4.0+6.1+7.7+7.7+13.0+4.5+37.3
Up moveDown movePending
AI summary

Gaudium IVF filed a corrigendum to fix minor typographical and regrouping errors in FY25 comparative figures appearing in its consolidated FY26 results. FY25 PAT was understated by 20.13 lakhs and is now corrected to 1,913.13 lakhs. Current year FY26 figures remain unchanged. Auditors confirmed no revision needed. For FY26, standalone revenue grew 21 percent to 7,158 lakhs and PAT rose 20 percent to 2,229 lakhs. Consolidated revenue jumped 48 percent to 10,436 lakhs with PAT up 28 percent to 2,449 lakhs. The company listed in February 2026 after a 90 crore IPO.

Likely market impact

No material impact on FY26 financials. Prior year comparatives corrected upward slightly. Strong FY26 revenue and profit growth signals positive momentum for shareholders.